Boyer Derek, Quintanilla Rene, Lee-Fruman Kay K
Department of Biological Sciences, California State University at Long Beach, Long Beach, CA 90840, USA.
Mol Cell Biochem. 2008 Jan;307(1-2):59-64. doi: 10.1007/s11010-007-9584-5. Epub 2007 Sep 5.
Ribosomal S6 kinase 2 (S6K2) is one of the kinases regulated by the mammalian target of rapamycin (mTOR) signaling pathway. Although it has been identified as a kinase homologous to S6K1, evidence suggests that the two kinases have non-overlapping functions, and the biological function of S6K2 still remains unknown. In order to identify the cell cycle stage(s) during which S6K2 plays a role, we assessed changes in the catalytic activity of S6K2 throughout the cell cycle. Our data show that S6K2 is active throughout the cell cycle with higher activity in G2 and M phases. We also show that S6K1 activity peaks sharply during M phase. Our data suggest that S6K1 and S6K2 likely play yet-unknown roles in G2 and M phases.
核糖体S6激酶2(S6K2)是受雷帕霉素哺乳动物靶标(mTOR)信号通路调控的激酶之一。尽管它已被鉴定为与S6K1同源的激酶,但有证据表明这两种激酶具有不重叠的功能,并且S6K2的生物学功能仍然未知。为了确定S6K2发挥作用的细胞周期阶段,我们评估了整个细胞周期中S6K2催化活性的变化。我们的数据表明,S6K2在整个细胞周期中都有活性,在G2期和M期活性更高。我们还表明,S6K1活性在M期急剧达到峰值。我们的数据表明,S6K1和S6K2可能在G2期和M期发挥尚未知晓的作用。